Mondaq Middle East & Africa - Saudi Arabia: Food, Drugs, Healthcare, Life Sciences
Al Tamimi & Company
Establishing a hospital in the MENA region or investing into an existing medical facility is of significant interest for investors globally.
Al Tamimi & Company
In an era where picture-perfect images of flawless men and women flash before our eyes constantly, the pressure of maintaining a perfect appearance is mounting in our society.
Al Tamimi & Company
A relatively new regulation has been introduced in Jordan, which is the Regulation for Licensing Home Healthcare Institutions No. 84 of 2016 (the ‘Regulation').
Al Tamimi & Company
Saudi Arabia's ambitious programme of social and economic renewal, Vision 2030 (announced in April 2016), has healthcare squarely in its sights.
Al Tamimi & Company
For the pharmaceutical industry and for governmental regulators, counterfeit medications remain a top concern not only in the MENA region, but globally.
Shearman & Sterling LLP
Reform of how public healthcare and related services are delivered in the Kingdom is one of the Government's most important priorities.
Clyde & Co
It is known that SAGIA towards the end of 2016 and earlier on 2017 has started issuing trading license to a number of international pharmaceutical companies through a 100% structure or Joint Venture.
Shearman & Sterling LLP
The Kingdom of Saudi Arabia is widely recognised as having the largest and fastest growing population in the Gulf Cooperation Council (the "GCC"), with over half the population under 40.
Clyde & Co
Other human healthcare services CPC 9319 except CPC 93191" and excluding of course the services listed under the Negative List.
Al Tamimi & Company
The sensitive subject-matter of how to determine the best course of action with regard to the treatment, or other options, for a patient who is reaching the end of their life, who may be terminally ill...
Most Popular Recent Articles
Al Tamimi & Company
Establishing a hospital in the MENA region or investing into an existing medical facility is of significant interest for investors globally.
Al Tamimi & Company
In an era where picture-perfect images of flawless men and women flash before our eyes constantly, the pressure of maintaining a perfect appearance is mounting in our society.
Al Tamimi & Company
A relatively new regulation has been introduced in Jordan, which is the Regulation for Licensing Home Healthcare Institutions No. 84 of 2016 (the ‘Regulation').
Al Tamimi & Company
Saudi Arabia's ambitious programme of social and economic renewal, Vision 2030 (announced in April 2016), has healthcare squarely in its sights.
Shearman & Sterling LLP
The Kingdom of Saudi Arabia is widely recognised as having the largest and fastest growing population in the Gulf Cooperation Council (the "GCC"), with over half the population under 40.
Al Tamimi & Company
The sensitive subject-matter of how to determine the best course of action with regard to the treatment, or other options, for a patient who is reaching the end of their life, who may be terminally ill...
Al Tamimi & Company
For the pharmaceutical industry and for governmental regulators, counterfeit medications remain a top concern not only in the MENA region, but globally.
Shearman & Sterling LLP
Reform of how public healthcare and related services are delivered in the Kingdom is one of the Government's most important priorities.
Clyde & Co
Other human healthcare services CPC 9319 except CPC 93191" and excluding of course the services listed under the Negative List.
Clyde & Co
It is known that SAGIA towards the end of 2016 and earlier on 2017 has started issuing trading license to a number of international pharmaceutical companies through a 100% structure or Joint Venture.
Article Search Using Filters
Related Topics
Popular Authors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter